Trump touts malaria drugs in trials for COVID-19
The president held hopes that drugs scheduled for clinical trials showed promise
PROVIDENCE, R.I. (WLNE)- President Donald Trump, addressing the nation at an afternoon press conference, praised the use of anti-malaria drugs he said showed promise toward fighting COVID-19.
“I’m pleased to report that clinical trials in New York will begin for existing drugs that may prove effective against the virus,” Trump said.
Trump claimed that large quantities of cholorquine, an anti-malaria drug, and the antibiotic commonly referred to as Z-Pak, would be made available tomorrow for clinical testing.
The drugs have not previously been tested in a clinical trial for use in combating the novel coronavirus currently shutting down large portions of the globe, but Trump offered anecdotal evidence that they had been effective.
The president seemed certain that the timeline for a return to a more typical way-of-life was on the horizon.
“A lot sooner than 3 or 4 months, as somebody has suggested,” Trump said.
The president repeated his assertion that repairing the nation’s economy remained his top goal.
“This is a medical problem,” Trump said, “we’re not going to let it turn into a long-lasting financial problem.”
©WLNE-TV/ABC 6 2020